Investing Profile

Julie Grant

VCInvestor
General Partner at Canaan
canaan.com/team/julie-grantSan Francisco Bay Area
Photo of Julie Grant, General Partner at Canaan Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Katapult Accelerator Network
1377 CONNECTIONS
Goldman Sachs Network
1034 CONNECTIONS
Moving Capital Network
962 CONNECTIONS
SloCloth Network
810 CONNECTIONS
Yale University Network
416 CONNECTIONS
cb
Canaan Partners General Partner
$250K - $20.0M
$10.0M
8
$800M

Sign in to see all 5 investments on record.

Sign in with Google →
General Partner CanaanPresent
Co-Founder and Chief Executive Officer Day One BiopharmaceuticalsPresent
Partner CanaanPresent
Chair Of The Board Of Directors Day One BiopharmaceuticalsPresent
Board Member SynthekinePresent
Board Member Nocion Therapeutics, Inc.Present
Board Member Biden Cancer InitiativePresent
Board Member Protagonist TherapeuticsPresent
Board Observer GlookoPresent
Principal CanaanPresent
Board Observer Moving CapitalPresent
Seed Investor and Board Observer Cellular ResearchPresent
Board Observer CytomX TherapeuticsPresent
Board Observer ALDEA PharmaPresent
Board Observer Dermira, Inc.Present
Associate CanaanPresent
Board Observer LABRYS BIOLOGICS, INC.Present
Market Planning Manager - BioOncology New Products Lead GenentechPresent
Market Planning Manager - Tarceva GenentechPresent
BioOncology Project Manager GenentechPresent
Business Development Intern GenentechPresent
Licensing Intern Yale UniversityPresent
Summer Analyst, Americas Special Situations Group Goldman SachsPresent
Board Observer Katapult AcceleratorPresent
Board Observer Chrono TherapeuticsPresent
Board Observer SloClothPresent
Yale University B.S. Molecular Biophysics and biochemistry
University of Cambridge MPhil BioScience Enterprise
Sign in with Google →
Sign in with Google →